The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis ; volume:20 ; number:1 ; day:21 ; month:9 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cancer ; 20, Heft 1 (21.9.2020), 1-9, 12.2020
- Urheber
-
Vuong, Huy Gia
Nguyen, Thu Quynh
Ngo, Tam N. M.
Nguyen, Hoang Cong
Fung, Kar-Ming
Dunn, Ian F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-07364-5
- URN
-
urn:nbn:de:101:1-2020110820190997009641
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vuong, Huy Gia
- Nguyen, Thu Quynh
- Ngo, Tam N. M.
- Nguyen, Hoang Cong
- Fung, Kar-Ming
- Dunn, Ian F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Human TERT promoter mutations as a prognostic biomarker in glioma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Frequency of TERT Promoter Mutations in Prostate Cancer
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Human TERT promoter mutations as a prognostic biomarker in glioma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
Frequency of TERT Promoter Mutations in Prostate Cancer
Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
Human TERT promoter mutations as a prognostic biomarker in glioma
Prognostic Impact of the Combination of MGMT Methylation and TERT Promoter Mutation in Glioblastoma
O6-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
TERT promoter hotspot mutations in breast cancer
Mechanistic basis of atypical TERT promoter mutations
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF V600E /TERT promoter double-mutated glioma
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas